Collagen induction

Collagen induction, frequently referred to as neocollagenesis, is a physiological process rather than a single molecular target or receptor. It describes the stimulated production of collagen fibers—predominantly Type I and Type III—by fibroblasts within the dermis and other connective tissues (https://pubmed.ncbi.nlm.nih.gov/24356395/). This process is a primary goal in aesthetic medicine and dermatology for treating skin laxity, wrinkles, and scars, where it is triggered by various modalities including topical retinoids, chemical peels, microneedling, and laser therapies (https://www.ncbi.nlm.nih.gov/books/NBK459344/). At a molecular level, collagen induction is typically mediated by the release of growth factors like TGF-β and PDGF during the wound healing cascade, which promotes the transcription of collagen genes (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3583892/). While essential for tissue repair and skin rejuvenation, dysregulated or excessive collagen induction can lead to pathological conditions such as keloids or internal organ fibrosis. Because it is a complex biological outcome involving multiple pathways and cell types, 'Collagen induction' is classified as a therapeutic effect or biological process rather than a discrete drug target.

Other names

NeocollagenesisCollagen stimulationCollagen induction therapyECM remodeling

Collagen induction occurs via the activation of fibroblasts, often through the TGF-beta signaling pathway, in response to controlled mechanical, chemical, or thermal stimuli. This leads to the synthesis of procollagen, which is subsequently processed into mature Type I and Type III collagen fibers in the extracellular matrix (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4976400/).